GenEdit

Category

2016

About This Project

GenEdit is a genome editing company with novel therapeutics. Their approach enables precise DNA sequence editing to cure severe diseases at a molecular level by delivering the breakthrough CRISPR/Cas9 protein. GenEdit raised a $1.5M seed round during the summer of 2016 led by Sequoia.